<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="http://www.feuxdelamour.com/v4/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="fr">
		<id>http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=Staurosporine_Information_And_Also_Urban_Myths</id>
		<title>Staurosporine Information And Also Urban Myths - Historique des versions</title>
		<link rel="self" type="application/atom+xml" href="http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=Staurosporine_Information_And_Also_Urban_Myths"/>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=Staurosporine_Information_And_Also_Urban_Myths&amp;action=history"/>
		<updated>2026-06-14T06:17:07Z</updated>
		<subtitle>Historique pour cette page sur le wiki</subtitle>
		<generator>MediaWiki 1.20alpha</generator>

	<entry>
		<id>http://www.feuxdelamour.com/v4/index.php?title=Staurosporine_Information_And_Also_Urban_Myths&amp;diff=168912&amp;oldid=prev</id>
		<title>Scenecold6 : Staurosporine Information And Also Urban Myths</title>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=Staurosporine_Information_And_Also_Urban_Myths&amp;diff=168912&amp;oldid=prev"/>
				<updated>2017-08-16T01:15:55Z</updated>
		
		<summary type="html">&lt;p&gt;Staurosporine Information And Also Urban Myths&lt;/p&gt;
&lt;p&gt;Can't load revision 168912&lt;/p&gt;</summary>
		<author><name>Scenecold6</name></author>	</entry>

	<entry>
		<id>http://www.feuxdelamour.com/v4/index.php?title=Staurosporine_Information_And_Also_Urban_Myths&amp;diff=78139&amp;oldid=prev</id>
		<title>Scenecold6 : Page créée avec « The trial was registered in clinicaltrials.gov (ID: NCT02088502). Sample size was calculated using the G*Power software (version 3.1.7, Universit?t Kiel, Germany). Conside... »</title>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=Staurosporine_Information_And_Also_Urban_Myths&amp;diff=78139&amp;oldid=prev"/>
				<updated>2017-03-14T08:29:43Z</updated>
		
		<summary type="html">&lt;p&gt;Page créée avec « The trial was registered in clinicaltrials.gov (ID: NCT02088502). Sample size was calculated using the G*Power software (version 3.1.7, Universit?t Kiel, Germany). Conside... »&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nouvelle page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;The trial was registered in clinicaltrials.gov (ID: NCT02088502). Sample size was calculated using the G*Power software (version 3.1.7, Universit?t Kiel, Germany). Considering the effect size of 0.3,11 significance level of 0.05, and study power of 0.8, a total sample of 32 patients in each group was required. Patients in the theophylline group received200 mg slow-release theophylline tablet (Darupakhsh Co., Tehran, [http://www.selleckchem.com/products/dorsomorphin-2hcl.html Dorsomorphin] Iran) plus placebo, and patients in the N-acetylcysteine group received600 mg non-effervescent N-acetylcysteine tablet (Shafa Co., Tehran, Iran) plus placebo, twice daily, from 24 h before to 48 h after administration of contrast material. Patients in theophylline plus N-acetylcysteine group received both drugs in the same order. All patients were hydrated with 0.9% sodium chloride (1 ml/kg/h) for 24 h, started 12 h before operation. Patients with left-ventricular ejection fraction of less than 40% or New York Heart Association functional class of III-IV were hydrated at rate of 0.5 ml/kg/h. Angiography �� angioplasty was done according to the clinical standards, by trans-femoral or trans-radial approach. In all cases, Iodixanol (Visipaque?, Amersham Healthcare, Cork, Ireland) was used as a non-ionic contrast media with low contrast osmolality. Before the operation, all the patients underwent a detailed history and physical examination by a cardiologist. [http://www.selleckchem.com/products/Staurosporine.html Staurosporine datasheet] Age, gender, and history of hypertension, diabetes mellitus, dyslipidemia, and smoking were recorded, and weight [http://en.wikipedia.org/wiki/Resminostat Resminostat] was measured. Cardiopulmonary examination was done for the evaluation of heart failure and systolic/diastolic blood pressure. Complete blood count was checked for anemia before operation. The volume of contrast material used was recorded for each patient. Serum creatinine was measured before and 48 h after contrast material injection in a hospital laboratory and the amount of change was considered as the study outcome. CIN was defined as an increase in serum creatinine level of �� 0.5 mg/dl or �� 25% of the baseline creatinine after 48 h of contrast material injection.18 Data were analyzed using the SPSS software for Windows (version 16.0, SPSS Inc., Chicago, IL, USA). Data are presented as mean �� standard deviation or number (%). The chi-square test was applied for comparison of qualitative data between groups. Quantitative data were checked if normally distributed in each group using the Kolmogorov-Smirnov Test. If data were normally distributed, the ANOVA test (with Tukey post-hoc) was applied for comparisons among the three study groups. If data was not normally distributed, the Kruskal-Wallis test was applied, followed by the Mann-Whitney U-test for comparisons between each two pairs. The Wilcoxon test was applied for within-group comparisons. Furthermore, the ANCOVA test was done for controlling the effects of covariates. P&lt;/div&gt;</summary>
		<author><name>Scenecold6</name></author>	</entry>

	</feed>